相关实验视频

Updated: Mar 6, 2026

Cerebellar Regional Dissection for Molecular Analysis

Cerebellar Regional Dissection for Molecular Analysis

Published on: December 5, 2020

精神障碍和CaV2.1通道的结构缺陷在情节性动脉障碍类型2:使用AI预测模型的相关性

Hyo-Jung Kim¹, Jin-Ok Lee², Sejoon Lee^3,4

¹Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, South Korea.

Journal of neurology

|March 4, 2026

概括

由AI预测的CaV2.1通道的结构变化与Episodic Ataxia type 2 (EA2) 患者的智力功能有很强的相关性. 这表明CaV2.1通道中断有助于EA2的认知缺陷.

科学领域:

神经遗传学神经遗传学
计算生物学计算生物学
分子神经科学分子神经科学

背景情况:

2型 (EA2) 插曲性动与CACNA1A中的致病变体有关,该变体编码了CaV2.1 P/Q型通道.
在EA2中认知障碍背后的精确分子机制仍然不完全理解.

研究的目的:

研究AI预测的CaV2.1通道结构变化与EA2患者的智能功能之间的相关性.
评估人工智能驱动的蛋白质建模在理解通道病变中的基因型-表型关系方面的实用性.

主要方法:

利用AlphaFold3来建模野生类型和变种CACNA1A蛋白质.
使用模板建模 (TM) 评分和计算相对氨基酸长度比率 (AA%) 的量化蛋白质结构相似性.
在13名EA2患者中,这些蛋白质水平指标与标准化智力指数相关联.

主要成果:

模板建模 (TM) 评分与智力指数有很强的相关性,包括全尺度智商 (FSIQ),口头理解指数 (VCI),感知推理指数 (PRI) 和工作记忆指数 (WMI).
氨基酸长度比率 (AA%) 与VCI和WMI相关,但不如TM得分.
更高的结构相似性 (更高的TM得分) 与更好的智力功能相对应.

结论:

在EA2患者中,CaV2.1通道的结构完整性比蛋白质长度更能预测EA2患者的智力功能.
CaV2.1通道的结构性破坏可能导致EA2.2中观察到的认知障碍.
基于人工智能的蛋白质建模是将遗传变异与临床表型联系起来的强大工具,特别是在通道病变中.

关键词:

通道中的.头头这种情况.插曲性无氧反应 (Episodic ataxia) 是一种智力障碍智力障碍是一种智力障碍.尼斯塔格姆斯 (Nystagmus) 是一种的动物.

更多相关视频

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration

Published on: December 27, 2024

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

相关概念视频

Intellectual Disability

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...

Visual Agnosia

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...